The 𝟔𝟎𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 𝐨𝐟 𝐏𝐏𝐌𝐀 was successfully held at 𝐅𝐚𝐥𝐞𝐭𝐭𝐢’𝐬 𝐇𝐨𝐭𝐞𝐥, 𝐋𝐚𝐡𝐨𝐫𝐞, bringing together industry leaders, members, and stakeholders to review achievements, set future goals, and strengthen Pakistan’s pharmaceutical landscape. Together, we continue to advance innovation, quality, and global competitiveness in Pakistan’s pharma industry.
60th Annual General Meeting of PPMA Read More »
Advocating for fair and transparent valuation of raw and packaging material imports. This initiative reflects PPMA’s continued commitment to fostering policy reforms, industrial sustainability, and export competitiveness, ensuring that Pakistan’s pharmaceutical sector continues to grow as a pillar of national progress.
The 8th Pakistan Pharma Summit & PESA Awards 2025 brought together leaders, regulators & innovators in Islamabad. $30B export target set by Health Minister Syed Mustafa Kamal WHO, PIC/S & MHRA certifications termed essential Pharma exports up 34% (~USD 457M) ATCO, Getz, Herbion, PharmaEvo & more honored for excellence Pakistan’s pharma industry is not just
PESA 2025: Pharma’s Global Pride & Economic Strength Read More »
Home Secretary Punjab, alongside the Punjab Civil Defence Resilience Corps. The meeting reaffirmed 𝐏𝐏𝐌𝐀’𝐬 pledge to support the Government of Punjab by ensuring the availability of essential medicines and life-saving supplies for health drives and disaster-relief missions.
PPMA North Chairman Saad Javed Akram met Dr. Ahmed Javed Qazi Read More »
Visionary leaders Tauqeer ul Haq, Nawaz Ahmed, and Haroon Akhtar Khan came together at the summit — uniting vision, leadership, and innovation for Pakistan’s pharma future. Strengthening pharma exports & global competitiveness Fostering innovation and strategic partnerships Government-industry collaboration for growth With top policymakers, industry experts, and global stakeholders, the event set the stage for
IN FOCUS | 8th Pakistan Pharma Summit & PESA Awards 2025 Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
